Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Lundbeck agrees $658m deal to buy Chelsea Therapeutics

Lundbeck agrees $658m deal to buy Chelsea Therapeutics such as antidepressant Brintellix (vortioxetine) and Abilify Maintena (aripiprazole) to build sales momentum.

Double win for J&J's schizophrenia franchise

Double win for J&J's schizophrenia franchise leg-up in the market over competitors such as Lilly's Zypadhera (olanzapine) and Lundbeck's Abilify Maintena (aripiprazole), which has just been introduced in Europe.

Abilify Maintena launches in Europe

Abilify Maintena launches in Europe Lundbeck said today that Abilify Maintena will be on the market in 10 countries by the end of year. ... As a result Lundbeck is highlighting Abilify Maintena's ability to protect schizophrenia patients who have already been stabilised with oral

Pharma's winners and losers in 2013

Pharma's winners and losers in 2013 The company also faced declines for antipsychotic Abilify (aripiprazole) and irbesartan-based Avapro/Avalide for high blood pressure and growth of BMS' oncology and autoimmune disorder products could do little to

Otsuka/Lundbeck say brexpiprazole works in phase III trial

Otsuka/Lundbeck say brexpiprazole works in phase III trial On course as successor to antipsychotic Abilify. The first phase III data on Otsuka and Lundbeck's new antidepressant brexpiprazole is positive and will be presented at a conference in March, ... Abilify has already lost patent protection in a number of

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics